Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
DESCRIPTION: New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for chronic kidney disease (CKD). METHODS: The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment. POPULATION: This recommendation applies to asymptomatic adults without diagnosed CKD. Testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation. RECOMMENDATION: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults (I statement).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Current issues in measurement and reporting of urinary albumin excretion
Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.106567 · Cited by 381
Xue, J. L., Eggers, P. W., Agodoa, L. Y., Foley, R. N., & Collins, A. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050524 · Cited by 117 · cited 2×
“African Americans are 3 to 5 times more likely to have end-stage renal disease than white Americans (3, 4).”
Background
Cited by
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405
“79 However, this guidance must be revisited with the advent of several classes of medications now demonstrating benefit in slowing the progression of CKD (eg, ACE inhibitors/ARBs, SGLT2 inhibitors, and nonsteroidal mineralocorticoid receptor antagonists), preventing CVD events, and reducing…”
BackgroundRomagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Matsushita, K., Coresh, J., Sang, Y., Chalmers, J., Fox, C., Guallar, E., Jafar, T., Jassal, S. K., Landman, G. W. D., Muntner, P., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00040-6 · Cited by 903
Levey, A. S., Becker, C., & Inker, L. A. (2015) · JAMA · doi:10.1001/jama.2015.0602 · Cited by 591
Metadata
- Authors
- Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2012-10-16
- Volume
- 157
- Issue
- 8
- Pages
- 567-570
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2069408833
- Cited by
- 155
- References
- 3
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement. https://app.cochat.ai/papers/10.7326/0003-4819-157-8-201210160-00533
- The paper
- Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force*. (2012). Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-157-8-201210160-00533
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.